Revolutions Medical Corporation Announces Plans to Move Forward With Strategic Product Development To Test and Evaluate Its New Breakthrough MRI Software Technology

MOUNT PLEASANT, S.C.--(BUSINESS WIRE)--Revolutions Medical Corporation (PINK SHEETS: RMCP) today announced that the Company is presently moving forward with Strategic Product Development of Lexington, MA to integrate, test and evaluate applications for its MRI imaging software technology acquired in the Clear Image Acquisition transaction earlier this year. It is expected that the first series of testing will take place both domestically and internationally and will last approximately 120 days.